首页 > 最新文献

Mediastinum (Hong Kong, China)最新文献

英文 中文
Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a narrative review. 支气管内超声引导下经支气管纵隔冷冻生物切片检查:综述。
Pub Date : 2023-12-04 eCollection Date: 2024-01-01 DOI: 10.21037/med-23-34
Hema Yamini Ramarmuty, Masahide Oki

Background and objective: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive, safe, and well-established method for diagnosing and staging lung cancer and other conditions associated with mediastinal lymphadenopathy. Efforts have been made to enhance the material adequacy of EBUS-TBNA, including the recent introduction of EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TMC). This advancement facilitates the acquisition of larger and better-preserved tissue samples from the mediastinum. We evaluated the diagnostic accuracy and safety of EBUS-TMC in the diagnosis of malignant lesions and its effectiveness in relation to benign conditions, such as tuberculosis and sarcoidosis.

Methods: We searched the PubMed® database for relevant English articles published up to July 1, 2023. Subsequently, we conducted a comprehensive bibliographic analysis with a particular emphasis on diagnostic yield, safety profile, and procedural technicalities.

Key content and findings: Our narrative review, comprising seven publications, emphasizes the significance of EBUS-TMC as an effective technique for obtaining diagnostic tissue in malignant and benign conditions while maintaining an excellent safety profile. Furthermore, its capability for obtaining larger tissue samples facilitates molecular and immunological analysis in non-small cell lung cancer.

Conclusions: EBUS-TMC exhibits significant efficacy with regard to obtaining diagnostic tissue in malignant and benign conditions. However, further studies are needed to evaluate uncertainties regarding the selection of suitable cases and technical intricacies.

背景和目的:支气管内超声引导下经支气管针吸术(EBUS-TBNA)是一种微创、安全且行之有效的方法,用于诊断肺癌和其他纵隔淋巴结病相关疾病并对其进行分期。人们一直在努力提高 EBUS-TBNA 的材料充分性,包括最近推出的 EBUS 引导下经支气管纵隔冷冻活检(EBUS-TMC)。这一进步有助于从纵隔获取更大、保存更好的组织样本。我们评估了 EBUS-TMC 诊断恶性病变的准确性和安全性,以及与良性病变(如肺结核和肉样瘤病)相关的有效性:我们在 PubMed® 数据库中检索了截至 2023 年 7 月 1 日发表的相关英文文章。随后,我们进行了全面的文献分析,重点关注诊断率、安全性和程序技术:我们的叙述性综述包括七篇文献,强调了 EBUS-TMC 作为一种有效的技术在获取恶性和良性疾病诊断组织方面的重要性,同时保持了极佳的安全性。此外,EBUS-TMC还能获取较大的组织样本,有助于对非小细胞肺癌进行分子和免疫学分析:结论:EBUS-TMC 在获取恶性和良性病变的诊断组织方面具有显著疗效。然而,还需要进一步的研究来评估选择合适病例和技术复杂性方面的不确定性。
{"title":"Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a narrative review.","authors":"Hema Yamini Ramarmuty, Masahide Oki","doi":"10.21037/med-23-34","DOIUrl":"10.21037/med-23-34","url":null,"abstract":"<p><strong>Background and objective: </strong>Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive, safe, and well-established method for diagnosing and staging lung cancer and other conditions associated with mediastinal lymphadenopathy. Efforts have been made to enhance the material adequacy of EBUS-TBNA, including the recent introduction of EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TMC). This advancement facilitates the acquisition of larger and better-preserved tissue samples from the mediastinum. We evaluated the diagnostic accuracy and safety of EBUS-TMC in the diagnosis of malignant lesions and its effectiveness in relation to benign conditions, such as tuberculosis and sarcoidosis.</p><p><strong>Methods: </strong>We searched the PubMed<sup>®</sup> database for relevant English articles published up to July 1, 2023. Subsequently, we conducted a comprehensive bibliographic analysis with a particular emphasis on diagnostic yield, safety profile, and procedural technicalities.</p><p><strong>Key content and findings: </strong>Our narrative review, comprising seven publications, emphasizes the significance of EBUS-TMC as an effective technique for obtaining diagnostic tissue in malignant and benign conditions while maintaining an excellent safety profile. Furthermore, its capability for obtaining larger tissue samples facilitates molecular and immunological analysis in non-small cell lung cancer.</p><p><strong>Conclusions: </strong>EBUS-TMC exhibits significant efficacy with regard to obtaining diagnostic tissue in malignant and benign conditions. However, further studies are needed to evaluate uncertainties regarding the selection of suitable cases and technical intricacies.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"8 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139699081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hemiclamshell approach to bulky cervico-mediastinal lesions: how to do it. 半壳法治疗巨大的颈纵隔病变:如何做。
Pub Date : 2023-11-08 eCollection Date: 2024-01-01 DOI: 10.21037/med-23-36
Francesco Petrella, Stefania Maria Rita Rizzo

The hemiclamshell incision is a combination of partial median sternotomy and anterolateral thoracotomy, allowing excellent exposure of mediastinum, one pleural cavity and the neck. It can be used for superior sulcus tumors with mediastinal involvement or to resect bulky mediastinal lesions or lesions requiring cervical, mediastinal and pleural exposition. Although the vast majority of mediastinal lesions can now be approached by minimally invasive techniques, the hemiclamshell incision still plays a pivotal role in the case of bulky lesions involving cervical, mediastinal and pleural cavities. In the case of cardiac or great vessel involvement, the procedure should be performed in experienced high-volume centers with the availability of cardio-pulmonary bypass, extra-corporeal membrane oxygenator or venous shunts. Although the vast majority of mediastinal lesions can now be approached by minimally invasive techniques, the hemiclamshell incision still plays a pivotal role in the case of bulky lesions involving cervical, mediastinal and pleural cavities. It consists of a combination of subtotal median vertical sternotomy and antero-lateral thoracotomy in the 4th intercostal space, providing excellent exposure of the neck, mediastinum and one pleural cavity. The objective of this paper is to describe the standard steps for performing a hemiclamshell incision by using modern devices and technology which contribute to make this procedure easier, faster and safer.

半月形切口是胸骨部分正中切口和胸廓前外侧切口的组合,可以很好地暴露纵隔、一个胸膜腔和颈部。它可用于纵隔受累的上沟肿瘤,或切除体积较大的纵隔病变,或需要暴露颈部、纵隔和胸膜的病变。虽然现在绝大多数纵隔病变都可以通过微创技术进行治疗,但对于涉及颈腔、纵隔和胸膜腔的巨大病变,半月形切口仍起着关键作用。在心脏或大血管受累的情况下,手术应在经验丰富的大容量中心进行,并配备心肺旁路、体外膜氧合器或静脉分流术。虽然现在绝大多数纵隔病变都可以通过微创技术进行治疗,但对于涉及颈腔、纵隔和胸膜腔的巨大病变,半月形切口仍起着举足轻重的作用。它由胸骨正中次全垂直切口和第 4 肋间前外侧胸廓切口组合而成,能很好地暴露颈部、纵隔和一个胸膜腔。本文旨在介绍使用现代设备和技术进行半腔切口的标准步骤,这些设备和技术有助于使该手术更简单、更快捷、更安全。
{"title":"The hemiclamshell approach to bulky cervico-mediastinal lesions: how to do it.","authors":"Francesco Petrella, Stefania Maria Rita Rizzo","doi":"10.21037/med-23-36","DOIUrl":"10.21037/med-23-36","url":null,"abstract":"<p><p>The hemiclamshell incision is a combination of partial median sternotomy and anterolateral thoracotomy, allowing excellent exposure of mediastinum, one pleural cavity and the neck. It can be used for superior sulcus tumors with mediastinal involvement or to resect bulky mediastinal lesions or lesions requiring cervical, mediastinal and pleural exposition. Although the vast majority of mediastinal lesions can now be approached by minimally invasive techniques, the hemiclamshell incision still plays a pivotal role in the case of bulky lesions involving cervical, mediastinal and pleural cavities. In the case of cardiac or great vessel involvement, the procedure should be performed in experienced high-volume centers with the availability of cardio-pulmonary bypass, extra-corporeal membrane oxygenator or venous shunts. Although the vast majority of mediastinal lesions can now be approached by minimally invasive techniques, the hemiclamshell incision still plays a pivotal role in the case of bulky lesions involving cervical, mediastinal and pleural cavities. It consists of a combination of subtotal median vertical sternotomy and antero-lateral thoracotomy in the 4<sup>th</sup> intercostal space, providing excellent exposure of the neck, mediastinum and one pleural cavity. The objective of this paper is to describe the standard steps for performing a hemiclamshell incision by using modern devices and technology which contribute to make this procedure easier, faster and safer.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"8 ","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139699086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical review of spontaneous pneumomediastinum. 自发性气胸的临床回顾。
Pub Date : 2023-10-27 eCollection Date: 2024-01-01 DOI: 10.21037/med-23-25
Cynthia J Susai, Kian C Banks, Nathan J Alcasid, Jeffrey B Velotta

Primary spontaneous pneumomediastinum is a rare, often benign and self-limited condition defined by air within the mediastinum. However, correctly distinguishing primary spontaneous pneumomediastinum from secondary causes, especially esophageal perforation, remains a diagnostic challenge. There is significant debate regarding the balance of completing a thorough but not overly invasive and costly diagnostic workup. This clinical review aims to gather the limited data regarding spontaneous pneumomediastinum management from case series and retrospective cohort studies, and presents an evaluation algorithm and treatment plan stratified by clinical history. Understanding specifically if the patient presents with coughing versus forceful vomiting is critical to help elucidate the etiology and guide management of pneumomediastinum. Patients who present with forceful vomiting or retching should be considered with higher degree of suspicion for secondary causes of pneumomediastinum, specifically esophageal perforation. However, especially in children, aggressive diagnostic workup is not warranted in every case. After ruling out other etiologies of pneumomediastinum, spontaneous pneumomediastinum can be commonly treated with symptomatic management without the aggressive use of antibiotics or diet restriction. Hospital length of stay may also be minimized on a case-by-case basis. Overall, recurrence of spontaneous pneumomediastinum is rare and outpatient follow up may be safely limited to those at highest risk of recurrence.

原发性自发性纵隔气胸是一种罕见的、通常是良性的、自限性的疾病,由纵隔内的空气所决定。然而,如何正确区分原发性自发性纵膈气胸和继发性气胸,尤其是食管穿孔,仍然是一项诊断难题。对于如何平衡完成全面但又不过分侵入性和昂贵的诊断工作,存在着很大的争议。本临床综述旨在收集来自病例系列和回顾性队列研究的有关自发性气胸治疗的有限数据,并根据临床病史提出分层评估算法和治疗方案。具体了解患者是否伴有咳嗽或用力呕吐对于阐明病因和指导气胸的治疗至关重要。对于出现剧烈呕吐或反胃的患者,应高度怀疑继发性气胸的病因,特别是食管穿孔。然而,特别是对于儿童患者,并不是每个病例都需要进行积极的诊断检查。在排除了其他导致气胸的病因后,自发性气胸通常可以通过对症治疗来解决,而无需积极使用抗生素或限制饮食。也可根据具体情况尽量缩短住院时间。总的来说,自发性气胸很少复发,因此只需对复发风险最高的患者进行门诊随访即可。
{"title":"A clinical review of spontaneous pneumomediastinum.","authors":"Cynthia J Susai, Kian C Banks, Nathan J Alcasid, Jeffrey B Velotta","doi":"10.21037/med-23-25","DOIUrl":"10.21037/med-23-25","url":null,"abstract":"<p><p>Primary spontaneous pneumomediastinum is a rare, often benign and self-limited condition defined by air within the mediastinum. However, correctly distinguishing primary spontaneous pneumomediastinum from secondary causes, especially esophageal perforation, remains a diagnostic challenge. There is significant debate regarding the balance of completing a thorough but not overly invasive and costly diagnostic workup. This clinical review aims to gather the limited data regarding spontaneous pneumomediastinum management from case series and retrospective cohort studies, and presents an evaluation algorithm and treatment plan stratified by clinical history. Understanding specifically if the patient presents with coughing versus forceful vomiting is critical to help elucidate the etiology and guide management of pneumomediastinum. Patients who present with forceful vomiting or retching should be considered with higher degree of suspicion for secondary causes of pneumomediastinum, specifically esophageal perforation. However, especially in children, aggressive diagnostic workup is not warranted in every case. After ruling out other etiologies of pneumomediastinum, spontaneous pneumomediastinum can be commonly treated with symptomatic management without the aggressive use of antibiotics or diet restriction. Hospital length of stay may also be minimized on a case-by-case basis. Overall, recurrence of spontaneous pneumomediastinum is rare and outpatient follow up may be safely limited to those at highest risk of recurrence.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"8 ","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139699047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathological features of giant mediastinal tumors-a literature review. 巨大纵隔肿瘤的组织病理学特征--文献综述。
Pub Date : 2023-10-20 eCollection Date: 2023-01-01 DOI: 10.21037/med-23-23
Luka Brcic, Anja C Roden

Background and objective: Mediastinal lesions are uncommon. However, because of the vital structures in the mediastinum, large lesions specifically can lead to life-threatening situations. Treatment and management vary considerably with the disease. Therefore, the correct histopathologic diagnosis is important. Here we review lesions that have the potential to present as a giant lesion in the mediastinum. While we focus on the review of histopathologic, immunohistochemical (IHC), and molecular features of these lesions, clinical symptoms and characteristics and prognosis will also be discussed.

Methods: "Giant" was arbitrarily defined as a size of at least 10 cm in greatest dimension. The 2021 World Health Organization (WHO) classification of mediastinal tumors was searched for tumors reported to be larger than 10 cm. Tumors that can present as giant mediastinal lesions based on our own experience were also included. PubMed search was then performed for these lesions.

Key content and findings: A great variety of mediastinal lesions can present as giant mass. Those include for instance tumors of blood and lymph vessels, tumors of neurogenic origin, mesenchymal neoplasms, thymic epithelial tumors (TETs), and non-neoplastic cysts. Lesions range from benign to malignant. This review focuses on the most common lesions.

Conclusions: Many benign and malignant lesions can become a large mass in the mediastinum. Their correct diagnosis is important for the treatment and management of the patient.

背景和目的:纵隔病变并不常见。然而,由于纵隔内有重要结构,大的病变可能会危及生命。不同疾病的治疗和处理方法大不相同。因此,正确的组织病理学诊断非常重要。在此,我们将对纵隔中可能出现巨大病灶的病变进行回顾。我们将重点回顾这些病变的组织病理学、免疫组化(IHC)和分子特征,同时还将讨论临床症状和特征以及预后:"巨型 "的任意定义是最大尺寸至少为 10 厘米。在世界卫生组织(WHO)2021 年纵隔肿瘤分类中搜索了据报道大于 10 厘米的肿瘤。根据我们自己的经验,可表现为巨大纵隔病变的肿瘤也包括在内。然后对这些病变进行了PubMed搜索:各种纵隔病变均可表现为巨大肿块。这些病变包括血管和淋巴管肿瘤、神经源性肿瘤、间叶肿瘤、胸腺上皮肿瘤(TET)和非肿瘤性囊肿等。病变从良性到恶性不等。本综述侧重于最常见的病变:结论:许多良性和恶性病变都可能在纵隔内形成巨大肿块。正确诊断对患者的治疗和管理非常重要。
{"title":"Histopathological features of giant mediastinal tumors-a literature review.","authors":"Luka Brcic, Anja C Roden","doi":"10.21037/med-23-23","DOIUrl":"https://doi.org/10.21037/med-23-23","url":null,"abstract":"<p><strong>Background and objective: </strong>Mediastinal lesions are uncommon. However, because of the vital structures in the mediastinum, large lesions specifically can lead to life-threatening situations. Treatment and management vary considerably with the disease. Therefore, the correct histopathologic diagnosis is important. Here we review lesions that have the potential to present as a giant lesion in the mediastinum. While we focus on the review of histopathologic, immunohistochemical (IHC), and molecular features of these lesions, clinical symptoms and characteristics and prognosis will also be discussed.</p><p><strong>Methods: </strong>\"Giant\" was arbitrarily defined as a size of at least 10 cm in greatest dimension. The 2021 World Health Organization (WHO) classification of mediastinal tumors was searched for tumors reported to be larger than 10 cm. Tumors that can present as giant mediastinal lesions based on our own experience were also included. PubMed search was then performed for these lesions.</p><p><strong>Key content and findings: </strong>A great variety of mediastinal lesions can present as giant mass. Those include for instance tumors of blood and lymph vessels, tumors of neurogenic origin, mesenchymal neoplasms, thymic epithelial tumors (TETs), and non-neoplastic cysts. Lesions range from benign to malignant. This review focuses on the most common lesions.</p><p><strong>Conclusions: </strong>Many benign and malignant lesions can become a large mass in the mediastinum. Their correct diagnosis is important for the treatment and management of the patient.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"37"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138811189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative management and postoperative outcomes of locally advanced thymic epithelial tumors: a narrative review. 局部晚期胸腺上皮肿瘤的围手术期管理和术后效果:叙述性综述。
Pub Date : 2023-10-12 eCollection Date: 2024-01-01 DOI: 10.21037/med-23-24
Masaru Takenaka, Koji Kuroda, Fumihiro Tanaka

Background and objective: Thymic epithelial tumors (TETs) are frequently diagnosed at an advanced stage, highlighting the importance of understanding the treatment strategies for these cases. Surgical intervention after chemotherapy or chemoradiotherapy presents specific challenges and underscores the crucial role of perioperative management. This study aimed to explore the perioperative management and postoperative outcomes in patients with locally advanced TETs.

Methods: Relevant studies published between 2000 and 2022 were identified through PubMed searches using a combination of the following terms: "Locally advanced TETs", "Thymoma", "Thymic cancer", "Surgery", "Induction therapy", and "Postoperative outcomes". We analyzed available data to describe the perioperative management and postoperative outcomes of locally advanced TETs.

Key content and findings: Surgical outcomes after induction therapy for locally advanced TETs were analyzed for 18 references (total n=646) between 2000 and 2022. The primary objective of induction therapy for locally advanced TETs is complete tumor resection. In recent years, many medical centers have adopted systemic chemotherapy and chemoradiation for the treatment of thymoma and thymic carcinoma, respectively. During surgical intervention, resecting the surrounding organs, such as the lungs, pericardium, and phrenic nerves, is a common practice. Additionally, there may be cases wherein vascular resection of the superior vena cava (SVC) and innominate veins is necessary. Techniques and strategies for revascularization without complications are crucial in these situations. The incidence of postoperative complications varied significantly, ranging from 4.8% to 42%. However, perioperative mortality is typically reported to be approximately 0%, with only two reports showing mortality rates of 1.8% and 9.0%.

Conclusions: The short-term postoperative outcomes of surgical treatment following induction therapy for locally advanced TETs were generally deemed acceptable. However, incomplete resection may occur, particularly when the tumor invades the pulmonary artery or aorta. Hence, careful evaluation the indications for surgery is crucial, considering the patient's overall condition and treatment response.

背景和目的:胸腺上皮性肿瘤(TET)经常在晚期才被诊断出来,因此了解这些病例的治疗策略非常重要。化疗或化放疗后的手术干预是一项特殊的挑战,凸显了围手术期管理的关键作用。本研究旨在探讨局部晚期TET患者的围手术期管理和术后效果:通过使用以下术语组合在PubMed上进行搜索,确定了2000年至2022年间发表的相关研究:"局部晚期 TETs"、"胸腺瘤"、"胸腺癌"、"手术"、"诱导治疗 "和 "术后效果"。我们分析了现有数据,以描述局部晚期 TET 的围手术期管理和术后结果:我们分析了2000年至2022年间18篇参考文献(总计n=646)中局部晚期TET诱导治疗后的手术结果。局部晚期TET诱导治疗的主要目的是完全切除肿瘤。近年来,许多医疗中心分别采用全身化疗和化疗放疗来治疗胸腺瘤和胸腺癌。在手术治疗过程中,切除肺、心包和膈神经等周围器官是常见的做法。此外,还可能需要切除上腔静脉(SVC)和腹内静脉。在这些情况下,无并发症的血管再通技术和策略至关重要。术后并发症的发生率差异很大,从 4.8% 到 42% 不等。但据报道,围手术期死亡率通常约为 0%,只有两份报告显示死亡率分别为 1.8% 和 9.0%:局部晚期TET诱导治疗后手术治疗的术后短期疗效一般被认为是可以接受的。然而,可能会出现切除不彻底的情况,尤其是当肿瘤侵犯肺动脉或主动脉时。因此,考虑到患者的整体状况和治疗反应,仔细评估手术适应症至关重要。
{"title":"Perioperative management and postoperative outcomes of locally advanced thymic epithelial tumors: a narrative review.","authors":"Masaru Takenaka, Koji Kuroda, Fumihiro Tanaka","doi":"10.21037/med-23-24","DOIUrl":"10.21037/med-23-24","url":null,"abstract":"<p><strong>Background and objective: </strong>Thymic epithelial tumors (TETs) are frequently diagnosed at an advanced stage, highlighting the importance of understanding the treatment strategies for these cases. Surgical intervention after chemotherapy or chemoradiotherapy presents specific challenges and underscores the crucial role of perioperative management. This study aimed to explore the perioperative management and postoperative outcomes in patients with locally advanced TETs.</p><p><strong>Methods: </strong>Relevant studies published between 2000 and 2022 were identified through PubMed searches using a combination of the following terms: \"Locally advanced TETs\", \"Thymoma\", \"Thymic cancer\", \"Surgery\", \"Induction therapy\", and \"Postoperative outcomes\". We analyzed available data to describe the perioperative management and postoperative outcomes of locally advanced TETs.</p><p><strong>Key content and findings: </strong>Surgical outcomes after induction therapy for locally advanced TETs were analyzed for 18 references (total n=646) between 2000 and 2022. The primary objective of induction therapy for locally advanced TETs is complete tumor resection. In recent years, many medical centers have adopted systemic chemotherapy and chemoradiation for the treatment of thymoma and thymic carcinoma, respectively. During surgical intervention, resecting the surrounding organs, such as the lungs, pericardium, and phrenic nerves, is a common practice. Additionally, there may be cases wherein vascular resection of the superior vena cava (SVC) and innominate veins is necessary. Techniques and strategies for revascularization without complications are crucial in these situations. The incidence of postoperative complications varied significantly, ranging from 4.8% to 42%. However, perioperative mortality is typically reported to be approximately 0%, with only two reports showing mortality rates of 1.8% and 9.0%.</p><p><strong>Conclusions: </strong>The short-term postoperative outcomes of surgical treatment following induction therapy for locally advanced TETs were generally deemed acceptable. However, incomplete resection may occur, particularly when the tumor invades the pulmonary artery or aorta. Hence, careful evaluation the indications for surgery is crucial, considering the patient's overall condition and treatment response.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"8 ","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139699083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified subxiphoid thoracoscopic thymectomy for early-stage thymic tumor: case report. 改良剑突下胸腔镜胸腺切除术治疗早期胸腺瘤:病例报告。
Pub Date : 2023-10-09 eCollection Date: 2023-01-01 DOI: 10.21037/med-21-23
Jia-Hao Jiang, Yi Zhang, Jian-Yong Ding

Background: Minimally invasive thymectomy via subxiphoid is increasingly being used for thymic tumors. Limited by the small space behind the sternum, the subxiphoid approach is sometimes difficult to perform. In this study, we introduce a modified subxiphoid thoracoscopic thymectomy which is performed via subxiphoid approach using an auxiliary sternal retractor to elevate the sternal to create a larger space behind the sternum. Therefore, the phrenic nerves on both sides were revealed more clearly and the left innominate vein was mobilized safer and easier.

Case description: This study describes the treatment process of a 27-year-old female patient with an incidental finding of a thymic mass. Chest contrast computed tomography revealed a 35 mm × 25 mm lesion in the anterior mediastinum which might be adherent to the left innominate vein. A careful preoperative evaluation was well done and no contraindications to the operation were found. This patient underwent modified subxiphoid thoracoscopic thymectomy, successfully completed without complications occurred during the perioperative period. The patient was discharged home well on post-operative day 2. The pathological diagnosis was mature teratoma.

Conclusions: In conclusion, modified subxiphoid thoracoscopic thymectomy using an auxiliary sternal retractor makes minimally invasive thymectomy safer and simpler and is an alternative option for patients with early-stage thymic tumors.

背景:经剑突下微创胸腺切除术越来越多地被用于治疗胸腺肿瘤。受限于胸骨后的狭小空间,剑突下入路有时难以实施。在本研究中,我们介绍了一种改良的剑突下胸腔镜胸腺切除术,该术式通过剑突下入路进行,使用辅助胸骨牵引器抬高胸骨,在胸骨后创造更大的空间。因此,两侧膈神经显露得更清楚,左侧腹股沟静脉的移动也更安全、更容易:本研究描述了一名意外发现胸腺肿块的 27 岁女性患者的治疗过程。胸部造影剂计算机断层扫描显示前纵隔有一个 35 毫米 × 25 毫米的病灶,可能与左侧腹股沟静脉粘连。经过仔细的术前评估,没有发现任何手术禁忌症。该患者接受了改良剑突下胸腔镜胸腺切除术,手术顺利完成,围手术期未发生并发症。患者在术后第 2 天顺利出院回家。病理诊断为成熟畸胎瘤:总之,使用辅助胸骨牵开器的改良剑突下胸腔镜胸腺切除术使微创胸腺切除术更安全、更简单,是早期胸腺肿瘤患者的另一种选择。
{"title":"Modified subxiphoid thoracoscopic thymectomy for early-stage thymic tumor: case report.","authors":"Jia-Hao Jiang, Yi Zhang, Jian-Yong Ding","doi":"10.21037/med-21-23","DOIUrl":"https://doi.org/10.21037/med-21-23","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive thymectomy via subxiphoid is increasingly being used for thymic tumors. Limited by the small space behind the sternum, the subxiphoid approach is sometimes difficult to perform. In this study, we introduce a modified subxiphoid thoracoscopic thymectomy which is performed via subxiphoid approach using an auxiliary sternal retractor to elevate the sternal to create a larger space behind the sternum. Therefore, the phrenic nerves on both sides were revealed more clearly and the left innominate vein was mobilized safer and easier.</p><p><strong>Case description: </strong>This study describes the treatment process of a 27-year-old female patient with an incidental finding of a thymic mass. Chest contrast computed tomography revealed a 35 mm × 25 mm lesion in the anterior mediastinum which might be adherent to the left innominate vein. A careful preoperative evaluation was well done and no contraindications to the operation were found. This patient underwent modified subxiphoid thoracoscopic thymectomy, successfully completed without complications occurred during the perioperative period. The patient was discharged home well on post-operative day 2. The pathological diagnosis was mature teratoma.</p><p><strong>Conclusions: </strong>In conclusion, modified subxiphoid thoracoscopic thymectomy using an auxiliary sternal retractor makes minimally invasive thymectomy safer and simpler and is an alternative option for patients with early-stage thymic tumors.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138811345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathological snapshots of thymic epithelial tumors with invasion into neighboring structures: preparing for the forthcoming revision of the TNM classification. 胸腺上皮肿瘤侵犯邻近结构的病理快照:为即将修订的 TNM 分类做准备。
Pub Date : 2023-09-19 eCollection Date: 2023-01-01 DOI: 10.21037/med-23-28
Yosuke Yamada, Hironori Haga

Treatment decision-making of thymic epithelial tumors (TETs) after surgery is based on the pathological stage. Currently, most institutions use both the Masaoka-Koga system and the 8th edition of the tumor, node, metastasis (TNM) classification. Because these two systems separate each stage according to the same concept, namely, the "levels" of tumor extension, precise pathological evaluation of the presence or absence of tumor invasion into stage-defining structures is necessary. This review provides representative pathological snapshots of tumors invading neighboring structures to provide references that might be helpful to readers; the snapshots will cover features that correspond to those of "locally advanced TETs", the topic of this series. Tumor subtype, whether thymoma or thymic carcinoma, is another factor influencing treatment decisions. Accumulating evidence has indicated that most thymomas and thymic carcinomas have biologically distinct features. Representative results were achieved by a study conducted as part of The Cancer Genome Atlas (TCGA) project, and subsequent studies with the help of the TCGA data have further reported on these distinctive features. Here, we also introduce newly recognized features of TETs, mainly focusing on the difference between epithelial-rich thymomas and thymic squamous cell carcinoma. The new (9th) edition of the TNM classification will be launched in January 2024. Therefore, sharing current pathological features of TETs will help readers, not only in their daily practice but also in preparing for the upcoming classification system.

胸腺上皮肿瘤(TET)术后的治疗决策基于病理分期。目前,大多数机构都同时使用 Masaoka-Koga 系统和第 8 版肿瘤、结节、转移(TNM)分类法。由于这两个系统根据相同的概念(即肿瘤扩展的 "层次")来划分每个分期,因此有必要对肿瘤是否侵入分期结构进行精确的病理评估。本综述提供了肿瘤侵犯邻近结构的代表性病理快照,以提供可能对读者有帮助的参考资料;这些快照将涵盖与 "局部晚期 TET"(本系列的主题)相对应的特征。肿瘤亚型(胸腺瘤或胸腺癌)是影响治疗决策的另一个因素。越来越多的证据表明,大多数胸腺瘤和胸腺癌具有不同的生物学特征。癌症基因组图谱(The Cancer Genome Atlas,TCGA)项目的一项研究取得了具有代表性的结果,随后的研究在TCGA数据的帮助下进一步报道了这些独特的特征。在此,我们还介绍了新认识到的 TETs 特征,主要集中在富上皮性胸腺瘤与胸腺鳞状细胞癌之间的区别。新版(第 9 版)TNM 分类将于 2024 年 1 月推出。因此,分享 TET 目前的病理特征不仅有助于读者的日常实践,也有助于他们为即将到来的分类系统做好准备。
{"title":"Pathological snapshots of thymic epithelial tumors with invasion into neighboring structures: preparing for the forthcoming revision of the TNM classification.","authors":"Yosuke Yamada, Hironori Haga","doi":"10.21037/med-23-28","DOIUrl":"https://doi.org/10.21037/med-23-28","url":null,"abstract":"<p><p>Treatment decision-making of thymic epithelial tumors (TETs) after surgery is based on the pathological stage. Currently, most institutions use both the Masaoka-Koga system and the 8th edition of the tumor, node, metastasis (TNM) classification. Because these two systems separate each stage according to the same concept, namely, the \"levels\" of tumor extension, precise pathological evaluation of the presence or absence of tumor invasion into stage-defining structures is necessary. This review provides representative pathological snapshots of tumors invading neighboring structures to provide references that might be helpful to readers; the snapshots will cover features that correspond to those of \"locally advanced TETs\", the topic of this series. Tumor subtype, whether thymoma or thymic carcinoma, is another factor influencing treatment decisions. Accumulating evidence has indicated that most thymomas and thymic carcinomas have biologically distinct features. Representative results were achieved by a study conducted as part of The Cancer Genome Atlas (TCGA) project, and subsequent studies with the help of the TCGA data have further reported on these distinctive features. Here, we also introduce newly recognized features of TETs, mainly focusing on the difference between epithelial-rich thymomas and thymic squamous cell carcinoma. The new (9th) edition of the TNM classification will be launched in January 2024. Therefore, sharing current pathological features of TETs will help readers, not only in their daily practice but also in preparing for the upcoming classification system.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138811683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Size should not be an absolute contraindication: the case for robotic resection of ever larger anterior mediastinal masses. 大小不应成为绝对禁忌症:用机器人切除越来越大的前纵隔肿块的案例。
Pub Date : 2023-08-31 eCollection Date: 2023-01-01 DOI: 10.21037/med-23-29
Matthew M Rochefort
{"title":"Size should not be an absolute contraindication: the case for robotic resection of ever larger anterior mediastinal masses.","authors":"Matthew M Rochefort","doi":"10.21037/med-23-29","DOIUrl":"10.21037/med-23-29","url":null,"abstract":"","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"23"},"PeriodicalIF":0.0,"publicationDate":"2023-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/5b/med-07-23.PMC10493616.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10295528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining dogma and repealing of false rules-finding the true limits of medicine and surgery. 重新定义教条,废除错误规则--寻找医学和外科的真正极限。
Pub Date : 2023-08-27 eCollection Date: 2023-01-01 DOI: 10.21037/med-23-27
Paul L Linsky
{"title":"Redefining dogma and repealing of false rules-finding the true limits of medicine and surgery.","authors":"Paul L Linsky","doi":"10.21037/med-23-27","DOIUrl":"10.21037/med-23-27","url":null,"abstract":"","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"22"},"PeriodicalIF":0.0,"publicationDate":"2023-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/b6/med-07-22.PMC10493614.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10295530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resection of a giant mediastinal liposarcoma by median sternotomy with vascular reconstruction-a case report. 通过胸骨正中切开术切除巨大纵隔脂肪肉瘤并重建血管--病例报告。
Pub Date : 2023-08-10 eCollection Date: 2023-01-01 DOI: 10.21037/med-23-20
Michal Benej, Thomas Klikovits, Tibor Krajc, Stefan Watzka, Maximilian Hochmair, Dagmar Krenbek, Clemens Aigner

Background: Primary mediastinal liposarcoma is a rare malignancy of mesenchymal origin with local aggressive biological behavior which is often diagnosed as an incidental finding without any symptoms. Chemoresistance and low radiosensitivity of these tumors favors surgical resection as the only option for radical treatment. The potential need for extended resections of adjacent structures is not uncommon and could be challenging. Only a limited number of cases with successful vascular reconstruction for the treatment of mediastinal liposarcoma has been reported so far.

Case description: A 69-year-old female patient was admitted to our department with dry cough and a huge mediastinal mass for further investigation and treatment. Based on the results of preoperative examinations a mediastinal liposarcoma was suspected. The tumor was resected through median sternal incision with resection of the pericardium with subsequent mesh replacement and "en bloc" resection of the innominate vein with vascular graft reconstruction. The postoperative course was uneventful. Six months follow-up after surgery showed no signs of local recurrence or dissemination.

Conclusions: Extended resection and vascular reconstruction for the surgical treatment of primary mediastinal liposarcoma is often necessary to ensure adequate radicality and to reduce the risk of local recurrence. Therefore, these patients should be treated in high-volume centers with sufficient experience.

背景:原发性纵隔脂肪肉瘤是一种罕见的间质来源的恶性肿瘤,具有局部侵袭性生物学行为,通常作为无任何症状的偶然发现而被诊断。这些肿瘤的化疗抗药性和低放射敏感性使手术切除成为根治性治疗的唯一选择。可能需要扩大切除邻近结构的情况并不少见,而且可能具有挑战性。迄今为止,只有少数病例成功通过血管重建治疗纵隔脂肪肉瘤:一名 69 岁的女性患者因干咳和巨大纵隔肿块被送入我科接受进一步检查和治疗。根据术前检查结果,怀疑是纵隔脂肪肉瘤。通过胸骨正中切口切除了肿瘤,同时切除了心包,随后更换了网片,并 "整体 "切除了腹股沟静脉,进行了血管移植重建。术后恢复顺利。术后 6 个月的随访显示,没有出现局部复发或扩散的迹象:结论:在手术治疗原发性纵隔脂肪肉瘤时,通常需要进行扩大切除和血管重建,以确保足够的根治性并降低局部复发的风险。因此,这些患者应在经验丰富的大医院接受治疗。
{"title":"Resection of a giant mediastinal liposarcoma by median sternotomy with vascular reconstruction-a case report.","authors":"Michal Benej, Thomas Klikovits, Tibor Krajc, Stefan Watzka, Maximilian Hochmair, Dagmar Krenbek, Clemens Aigner","doi":"10.21037/med-23-20","DOIUrl":"https://doi.org/10.21037/med-23-20","url":null,"abstract":"<p><strong>Background: </strong>Primary mediastinal liposarcoma is a rare malignancy of mesenchymal origin with local aggressive biological behavior which is often diagnosed as an incidental finding without any symptoms. Chemoresistance and low radiosensitivity of these tumors favors surgical resection as the only option for radical treatment. The potential need for extended resections of adjacent structures is not uncommon and could be challenging. Only a limited number of cases with successful vascular reconstruction for the treatment of mediastinal liposarcoma has been reported so far.</p><p><strong>Case description: </strong>A 69-year-old female patient was admitted to our department with dry cough and a huge mediastinal mass for further investigation and treatment. Based on the results of preoperative examinations a mediastinal liposarcoma was suspected. The tumor was resected through median sternal incision with resection of the pericardium with subsequent mesh replacement and \"<i>en bloc</i>\" resection of the innominate vein with vascular graft reconstruction. The postoperative course was uneventful. Six months follow-up after surgery showed no signs of local recurrence or dissemination.</p><p><strong>Conclusions: </strong>Extended resection and vascular reconstruction for the surgical treatment of primary mediastinal liposarcoma is often necessary to ensure adequate radicality and to reduce the risk of local recurrence. Therefore, these patients should be treated in high-volume centers with sufficient experience.</p>","PeriodicalId":74139,"journal":{"name":"Mediastinum (Hong Kong, China)","volume":"7 ","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138811693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mediastinum (Hong Kong, China)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1